These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34329993)

  • 1. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Patel H; Chaudhari K; Jain P; Surana S
    Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities.
    Gao F; Chen Z; Ma L; Qiu L; Lin J; Lu G
    Bioorg Med Chem; 2019 Jun; 27(12):2652-2656. PubMed ID: 30992202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
    Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation.
    Sharma B; Kumar S; Preeti ; Johansen MD; Kremer L; Kumar V
    Chem Biol Drug Des; 2022 Feb; 99(2):301-307. PubMed ID: 34786862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
    Ding Z; Hou P; Liu B
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
    Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
    Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
    Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
    Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.
    Gl B; Rajput R; Gupta M; Dahiya P; Thakur JK; Bhatnagar R; Grover A
    Biochem J; 2020 Nov; 477(21):4167-4190. PubMed ID: 33030198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
    Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
    Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
    Carta A; Bua A; Corona P; Piras S; Briguglio I; Molicotti P; Zanetti S; Laurini E; Aulic S; Fermeglia M; Pricl S
    Eur J Med Chem; 2019 Jan; 161():399-415. PubMed ID: 30384044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
    Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives.
    Xu Y; Guan J; Xu Z; Zhao S
    Fitoterapia; 2018 Jun; 127():383-386. PubMed ID: 29631015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.
    Sampiron EG; Costacurta GF; Baldin VP; Almeida AL; Ieque AL; Santos NC; Alves-Olher VG; Vandresen F; Gimenes AC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Scodro RB
    Future Microbiol; 2019 Jul; 14():981-994. PubMed ID: 31382801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.